In breast cancer, FAP+CAFs are divided into 8 subgroups, among which the TGF-β signalling and extracellular matrix (ECM) -related subgroups are related to primary resistance to immunotherapy [10]. The gene discussed is FAP; the disease is breast carcinoma.